Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Hairless gene not strongly linked to baldness.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Mutations in the desmoplakin gene can cause hair problems and deadly heart disease.

Some women with PCOS have rare genetic variants linked to the condition.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

A new genetic area linked to a rare hair loss condition was found on chromosome 13 in a Chinese family.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Mutations in specific llama genes may affect fiber quality for textiles.

Thyroid issues can cause alopecia areata.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Certain gene variations in Jiangnan cashmere goats are linked to important traits like birth weight and fiber quality, useful for breeding.